Bupa has today announced the appointment of a new Group Medical Director, Dr Paul Zollinger-Read.
Paul joins Bupa from NHS Midlands and East Strategic Health Authority, where he is Director of Commissioning Development. He is also Medical Adviser and Primary Care Lead for the leading healthcare think-tank The King's Fund. Previously, Paul was the Chief Executive of five Primary Care Trusts, and a practising GP for over 20 years.
Paul replaces Dr Andrew Vallance-Owen, who has retired after 17 years at Bupa. Paul will be joining Bupa in the summer.
Bupa chief executive, Stuart Fletcher, said:
I'm delighted to welcome Paul to Bupa - he brings a wealth of healthcare skill and experience to his new role. Paul will ensure we continue to develop and sustain our world class standards of clinical governance and practice, continuing Andrew's excellent work and further strengthening our healthcare credentials.
I'm very excited to be joining the team at Bupa. I'm looking forward to further developing and deploying Bupa's healthcare expertise, realising our purpose to help people live longer, healthier, happier lives.
Notes to Editors
Paul Zollinger-Read studied medicine at Cambridge, and started his career as a GP in Braintree in 1991. He spent some time working with the NHS Modernisation Agency and, in 2002, set up and became CEO of one of the first Care Trusts in the country.
He went on to run the neighbouring PCT in Chelmsford and, following the reorganisation in 2006, was asked to run NHS North East Essex. At the beginning of 2009 Paul was asked to run NHS Great Yarmouth and Waveney PCT.
Paul became the Chief Executive of NHS Cambridgeshire in January 2010 and subsequently Chief Executive of NHS Peterborough in July 2010.
For further information contact:
Bupa Corporate Affairs
Tel: +44 (0)20 7656 2273
Bupa’s purpose is longer, healthier, happier lives.
A leading international healthcare group, we serve 13 million customers in more than 190 countries. We offer personal and company-financed health insurance and medical subscription products, run hospitals, provide workplace health services, home healthcare, health assessments and chronic disease management services. We are also a major international provider of nursing and residential care for elderly people.
With no shareholders, we invest our profits to provide more and better healthcare and fulfil our purpose.
Bupa employs more than 62,000 people, principally in the UK, Australia, Spain, Poland, New Zealand and the USA, as well as Saudi Arabia, Hong Kong, India, Thailand, China and across Latin America.
For more information, visit www.bupa.com.